Ardelyx, Inc. - Common Stock (NQ:ARDX)

3.235 -0.055 (-1.67%)

Delayed Quote Updated: 10:10 AM EST, Nov 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ardelyx, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

23 24 Next >

Ardelyx to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 2, 2023

February 23, 2023

Conference call scheduled for 4:30 p.m. Eastern Time

From Ardelyx, Inc.

Via GlobeNewswire

7 A-Rated Penny Stocks Worth Betting On ↗

February 19, 2023

Penny stocks tend to be more volatile than more so-called “established” stocks, so you have to be comfortable with your risk tolerance.

Via InvestorPlace

7 Stocks Under $10 to Buy in February ↗

February 17, 2023

A stock under $10 to buy is more likely to be a growth stock with a longer runway to providing investors with some great returns.

Via InvestorPlace

7 A-Rated Healthcare Stocks to Buy for the Future of Medicine ↗

February 12, 2023

Snapping up or adding to your positions in these healthcare stocks could be just what the doctor ordered for your portfolio.

Via InvestorPlace

Why Ardelyx Shares Are Falling ↗

January 19, 2023

Ardelyx Inc (NASDAQ: ARDX) shares are trading lower by 17.03% to $2.67 Thursday morning after the company filed for a mixed shelf offering of up to $250 million.

Via Benzinga

7 A-Rated Stocks to Buy for February 2023 ↗

February 07, 2023

Now's the time to pounce on these seven high-quality stocks to buy; each one earns an A rating in Portfolio Grader.

Via InvestorPlace

7 A-Rated Stocks to Buy for Less Than $25 ↗

January 24, 2023

These seven stocks to buy for less than $25 per share are strong opportunities in today's resilient yet uncertain market.

Via InvestorPlace

PPG Industries, Netflix, Ally Financial And Other Big Stocks Moving Higher On Friday ↗

January 20, 2023

U.S. stocks traded higher, with the Nasdaq Composite gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 19, 2023

Via Benzinga

5 Under-the-Radar Penny Stocks With 100% Upside Potential ↗

January 16, 2023

Most experts will advise you to steer clear of under the radar penny stocks – and for good reason. However, keep an eye on these.

Via InvestorPlace

Bulls In A Bear Market: These 10 Stocks Clocked Gains In Excess Of 100% In 2022 ↗

December 31, 2022

2022 would go down as one of the worst years for the financial markets. The sell-off has been all-pervasive, with stocks, bonds and cryptos all selling off indiscriminately. Even as high-fliers like...

Via Benzinga

Ardelyx To Rally 160%? Here Are 10 Other Price Target Changes For Friday ↗

December 30, 2022

Citigroup raised Ardelyx, Inc. (NASDAQ: ARDX) price target from $6 to $7. Citigroup analyst Yigal Nochomovitz maintained a Buy rating on the stock. Ardelyx shares rose 9.4% to $2.7685 on Friday.

Via Benzinga

Dow Surges 250 Points; Jobless Claims Rise To 225,000 ↗

December 29, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Thursday.

Via Benzinga

The 3 Biggest Opportunities for Penny Stock Investors in 2023 ↗

December 21, 2022

Investors should be able to profit from some of the biggest opportunities for penny stock investors identified in this column.

Via InvestorPlace

Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗

December 19, 2022

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.

Via Benzinga

Melco, Ardelyx And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

December 19, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Cosmos Health Inc. (NASDAQ: COSM) shares dipped 37.7% to $14.33 in...

Via Benzinga

FDA Needs More Time For Ardelyx's Appeal To Rejection Of Kidney Disease Candidate ↗

December 19, 2022

Via Benzinga

Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket ↗

December 19, 2022

Gainers AIM ImmunoTech Inc. (NYSE: AIM) shares rose 82.4% to $0.62 in pre-market trading. AIM ImmunoTech recently reported safety, tolerability and biological activity data for intranasal ampligen in...

Via Benzinga

The 7 Hottest Biotech Stocks to Own in 2023 and Beyond ↗

December 18, 2022

Biotech is one of the safest, recession-proof sectors on the market. It's why we're going after the hottest biotech stocks in the New Year.

Via InvestorPlace

How Is The Market Feeling About Ardelyx? ↗

December 07, 2022

Ardelyx's (NASDAQ:ARDX) short percent of float has risen 16.96% since its last report. The company recently reported that it has 8.59 million shares sold short, which is 4.62% of all regular shares...

Via Benzinga

Planned Government Move To Expand Access To Drugs For End-Stage Renal Disease Patients Could Shine The Spotlight On Unicycive ↗

December 07, 2022

In the U.S., reimbursement of dialysis expenses by the Centers for Medicare & Medicaid Services (CMS) is done using a prospective payment system (PPS) which enables the payout of a predetermined amount...

Via Benzinga

EXCLUSIVE: Top 10 Searched Tickers On Benzinga Pro In November 2022: Where Do Tesla, Apple, A Donald Trump-Linked SPAC Rank? ↗

December 05, 2022

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.

Via Benzinga

3 Biotech Stocks Smart Investors Should Be Buying Up Now ↗

November 24, 2022

These three biotech stocks could be among the best ways to play this uncertain market for those looking for long-term growth.

Via InvestorPlace

Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday ↗

November 23, 2022

U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Is Ardelyx is A Buy After Slip in Early 2022

November 21, 2022

Ardelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save them

Via MarketBeat

CapitalGainsReport Sector Spotlight: Healthcare Penny Stocks On The Move (ARDX, WHSI, BNGO)

November 21, 2022

Via AB Newswire

Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday ↗

November 21, 2022

Gainers AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday.

Via Benzinga

Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday ↗

November 21, 2022

U.S. stocks closed higher on Friday, with the Dow Jones gaining around 200 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

2 Biotech Stocks That Can Rocket Higher in 2023, According to Wall Street ↗

November 20, 2022

Recent analyst upgrades suggest these stocks can triple your money or better.

Via The Motley Fool

Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session ↗

November 18, 2022

Gainers PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital.

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.